Schroders Capital Global Innovation Trust plc - INOV (INOV) Fair Value & Analysis

Financial Services · GB · Market cap 109M GBX

What is Schroders Capital Global Innovation Trust plc - INOV really worth?

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• The rarer combination: high quality (78/100) AND below fair value. That earns a closer look rather than a quick verdict.
• The price is below even our cautious bear case (£0.2500). The market is more pessimistic than our downside scenario.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
• For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 31, 2026.

How to read this chart

60‑month range £0.0872 – £0.3600 · fair‑value band £0.2500 – £0.4200 · the £0.1745 price screens below the £0.3400 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 31, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Schroders Capital Global Innovation Trust plc - INOV (INOV) currently trades at £0.1745, while our model-based Fair Value estimate is £0.3400, implying the stock looks roughly 48.7% undervalued today. The Quality Score stands at 78/100 (high quality), in the Financial Services sector. Bull case: the Earnings-Based group reads highest at a median of £0.9100 per share, and 5 of the 6 models we run sit above the £0.1745 price. Bear case: the Asset-Based group reads lowest at £0.1500, and 1 of the 6 models stay below the price. Evidence for this calculation is low.

Over the trailing twelve months, Schroders Capital Global Innovation Trust plc - INOV generated revenue of £18.6M at a net margin of 88.8%. It earns a return on equity of 10.9%. Net debt stands at £2.9M. The stock trades on a trailing P/E of 8.7. Fundamentals as of Aug 31, 2026

Our scenario range runs from £0.2500 (bear case) to £0.4200 (bull case); at £0.1745, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Financial Services peers we cover trades at −28% fair-value upside, at 95%, INOV screens cheaper than that median.

Fair Value models

This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly £0.0136 per share, which is 4.0 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Widest divergence: Earnings-Based (£0.9100) versus Asset-Based (£0.1500). Highest evidence: Residual Income (71).

Key figures & financial health

Quality Score breakdown

About the company

Schroders Capital Global Innovation Trust plc - INOV specializes in investments in startups, midsize, middle market and large stage, early stage and mature stage investments. The fund primarily invests in the healthcare, financials, industrials, technology, consumer goods, telecommunications, basic materials, and biotechnology sector.

Full company description

Schroders Capital Global Innovation Trust plc - INOV specializes in investments in startups, midsize, middle market and large stage, early stage and mature stage investments. The fund primarily invests in the healthcare, financials, industrials, technology, consumer goods, telecommunications, basic materials, and biotechnology sector. It primarily invests in companies incorporated in the United Kingdom or traded on a London Stock Exchange market but can invest in Europe, United States and Asia other countries. The fund seeks to become a significant shareholder in the portfolio companies.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Schroders Capital Global Innovation Trust plc - INOV reported revenue of £17.5M in FY2025 versus £120M in FY2021, a compound −38.2%/yr. Reported net income was £16.5M in FY2025, compounding −38.9%/yr from FY2021.

Watch INOV: get an alert when its fair value changes →

Peer Group

Asset Management · 695 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Asset Management median · lower = cheaper

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Insider activity: 35/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Aug 31, 2026).

Explore undervalued stocks

More undervalued Financial Services stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions